Journal Home
Search for

Volume 75, Issue 1, Pages 42-57 (January 2006)


View previous. 5 of 13 View next.

The initial development of the WebMedQual scale: Domain assessment of the construct of quality of health web sites

Mélanie Provostemail address, Dayin Koompalum, Diane Dong, Bradley C. MartinCorresponding Author Informationemail address

Summary 

Objective

To develop a comprehensive instrument assessing quality of health-related web sites.

Methods

Phase I consisted of a literature review to identify constructs thought to indicate web site quality and to identify items. During content analysis, duplicate items were eliminated and items that were not clear, meaningful, or measurable were reworded or removed. Some items were generated by the authors. Phase II: a panel consisting of six healthcare and MIS reviewers was convened to assess each item for its relevance and importance to the construct and to assess item clarity and measurement feasibility.

Results

Three hundred and eighty-four items were generated from 26 sources. The initial content analysis reduced the scale to 104 items. Four of the six expert reviewers responded; high concordance on the relevance, importance and measurement feasibility of each item was observed: 3 out of 4, or all raters agreed on 76–85% of items. Based on the panel ratings, 9 items were removed, 3 added, and 10 revised. The WebMedQual consists of 8 categories, 8 sub-categories, 95 items and 3 supplemental items to assess web site quality. The constructs are: content (19 items), authority of source (18 items), design (19 items), accessibility and availability (6 items), links (4 items), user support (9 items), confidentiality and privacy (17 items), e-commerce (6 items).

Conclusion

The “WebMedQual” represents a first step toward a comprehensive and standard quality assessment of health web sites. This scale will allow relatively easy assessment of quality with possible numeric scoring.

Department of Clinical and Administrative Pharmacy, College of Pharmacy, The University of Georgia, Athens, GA 30602-2354, USA

Corresponding Author InformationCorresponding author.

 This work was presented when M. Provost and D. Koompalum were doctoral candidates. B. Martin is now Associate Professor and Director of Pharmaceutical Evaluation and Policy at the University of Arkansas College of Pharmacy.

PII: S1386-5056(05)00148-6

doi:10.1016/j.ijmedinf.2005.07.034


View previous. 5 of 13 View next.